BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6922785)

  • 1. Prostaglandin E1 treatment for neonatal heart defects.
    Carey BE
    Dimens Crit Care Nurs; 1982; 1(5):275-83. PubMed ID: 6922785
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin E1 for infants with congenital heart disease.
    Sasso SC
    MCN Am J Matern Child Nurs; 1983; 8(1):29. PubMed ID: 6401340
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological manipulation of the ductus arteriosus.
    Silove ED
    Arch Dis Child; 1986 Sep; 61(9):827-9. PubMed ID: 3767410
    [No Abstract]   [Full Text] [Related]  

  • 4. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 5. Care of the infant with ductus-dependent congenital heart disease receiving prostaglandin E1.
    Stachura L
    Issues Compr Pediatr Nurs; 1984; 7(4-5):203-15. PubMed ID: 6569057
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandin E1 in suspected ductus dependent cardiac malformation.
    Hallidie-Smith KA
    Arch Dis Child; 1984 Nov; 59(11):1020-6. PubMed ID: 6542338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease.
    Ringel RE; Brenner JI; Haney PJ; Burns JE; Moulton AL; Berman MA
    Radiology; 1982 Mar; 142(3):657-8. PubMed ID: 7199748
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.
    Heymann MA; Clyman RI
    Pharmacotherapy; 1982; 2(3):148-55. PubMed ID: 6763200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative ketotic hyperglycemia during prostaglandin E1 infusion in infancy.
    Cohen MH; Nihill MR
    Pediatrics; 1983 May; 71(5):842-4. PubMed ID: 6682218
    [No Abstract]   [Full Text] [Related]  

  • 10. [Skeletal side effects of treatment with prostaglandin E1].
    Persigehl M; Hövels-Gürich H; von Bernuth G
    Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants].
    Dymnicka S; Bielińska B; Ereciński J; Machnowski W
    Pediatr Pol; 1981 Oct; 56(10):1243-8. PubMed ID: 7199703
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostaglandin E1.
    Noerr B
    Neonatal Netw; 1991 Mar; 9(6):66-7. PubMed ID: 2000081
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of prostaglandin-induced cortical hyperostosis in an infant.
    Alpert BS; Jureidini SB; Vanderzalm T
    South Med J; 1984 Aug; 77(8):1039-40. PubMed ID: 6540475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term low-dose prostaglandin E1 administration.
    Sone K; Tashiro M; Fujinaga T; Tomomasa T; Tokuyama K; Kuroume T
    J Pediatr; 1980 Nov; 97(5):866-7. PubMed ID: 7431186
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of prostaglandin E1 and E2 in the management of neonatal heart disease.
    Olley PM; Coceani F; Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():345-53. PubMed ID: 645511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cortical hyperostoses after long-term prostaglandin E2 therapy].
    Benz-Bohm G; Emons D; Schickendantz S; Mallmann R; Redel D; Knöpfle G; Mennicken U
    Radiologe; 1984 Feb; 24(2):72-8. PubMed ID: 6369389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS; Nihill MR; Titus JL
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term prostaglandin E1 therapy in congenital heart defects.
    Teixeira OH; Carpenter B; MacMurray SB; Vlad P
    J Am Coll Cardiol; 1984 Mar; 3(3):838-43. PubMed ID: 6537955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.